These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 23611776

  • 1. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ, Kim KN, Heo SJ, Han SC, Kim J, Ko YJ, Kang HK, Yoo ES.
    Biochem Biophys Res Commun; 2013 May 17; 434(4):892-7. PubMed ID: 23611776
    [Abstract] [Full Text] [Related]

  • 2. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS, Ma CJ, Kim DS, Ma JY.
    J Med Food; 2011 Nov 17; 14(11):1439-47. PubMed ID: 21883017
    [Abstract] [Full Text] [Related]

  • 3. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
    J Cell Physiol; 2009 Dec 17; 221(3):618-28. PubMed ID: 19653230
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W, Dou H, Liu X, Sun L, Hou Y.
    Clin Exp Pharmacol Physiol; 2012 Oct 17; 39(10):886-93. PubMed ID: 23013134
    [Abstract] [Full Text] [Related]

  • 5. Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways.
    van Heerden B, Kasonga A, Kruger MC, Coetzee M.
    Nutrients; 2017 Apr 28; 9(5):. PubMed ID: 28452958
    [Abstract] [Full Text] [Related]

  • 6. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways.
    Ma X, Liu Y, Zhang Y, Yu X, Wang W, Zhao D.
    Biochem Biophys Res Commun; 2014 Mar 07; 445(2):282-8. PubMed ID: 24491533
    [Abstract] [Full Text] [Related]

  • 7. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM, Bhattacharya A, Fernandes G.
    J Lipid Res; 2006 Aug 07; 47(8):1739-48. PubMed ID: 16702601
    [Abstract] [Full Text] [Related]

  • 8. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 07; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 9. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.
    Ang ES, Pavlos NJ, Chai LY, Qi M, Cheng TS, Steer JH, Joyce DA, Zheng MH, Xu J.
    J Cell Physiol; 2009 Dec 07; 221(3):642-9. PubMed ID: 19681045
    [Abstract] [Full Text] [Related]

  • 10. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G, Wang FF, Li T, Jia DD, Shen Y, Xu HC.
    Med Sci Monit; 2018 Apr 26; 24():2569-2577. PubMed ID: 29698379
    [Abstract] [Full Text] [Related]

  • 11. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J.
    J Bone Miner Res; 2003 Dec 26; 18(12):2159-68. PubMed ID: 14672351
    [Abstract] [Full Text] [Related]

  • 12. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, Du SX.
    Cell Physiol Biochem; 2012 Dec 26; 30(1):123-36. PubMed ID: 22759961
    [Abstract] [Full Text] [Related]

  • 13. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 14. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
    Kim JL, Kang MK, Gong JH, Park SH, Han SY, Kang YH.
    Mol Nutr Food Res; 2012 Aug 13; 56(8):1223-33. PubMed ID: 22700286
    [Abstract] [Full Text] [Related]

  • 15. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.
    Rahman MM, Bhattacharya A, Fernandes G.
    J Cell Physiol; 2008 Jan 13; 214(1):201-9. PubMed ID: 17929247
    [Abstract] [Full Text] [Related]

  • 16. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE, Jung IT, Choi J, Baek YH, Lee JD, Park DS, Choi DY.
    Eur J Pharmacol; 2013 Jan 05; 698(1-3):57-66. PubMed ID: 22985747
    [Abstract] [Full Text] [Related]

  • 17. A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NFκB and MAPK signaling in RAW264.7 cells.
    Nikhil K, Sharan S, Roy P.
    Pharmacol Rep; 2015 Dec 05; 67(6):1264-72. PubMed ID: 26481551
    [Abstract] [Full Text] [Related]

  • 18. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC, Takada Y, Aggarwal BB.
    J Immunol; 2004 May 15; 172(10):5940-7. PubMed ID: 15128775
    [Abstract] [Full Text] [Related]

  • 19. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G, Zhou L, Shi X, He W, Wang H, Wei Q, Chen P, Qi L, Tickner J, Lin L, Xu J.
    Int J Mol Sci; 2017 Jan 19; 18(1):. PubMed ID: 28106828
    [Abstract] [Full Text] [Related]

  • 20. Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells.
    Zeng YP, Yang C, Li Y, Fan Y, Yang HJ, Liu B, Sang HX.
    Mol Med Rep; 2016 Sep 19; 14(3):1957-62. PubMed ID: 27430169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.